Insider Transactions Reported by 21 Insiders of BridgeBio Pharma, Inc.

Symbol
BBIO on Nasdaq
Location
Palo Alto, CA

Insiders trading volume in the past year

BridgeBio Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viking Global Investors Lp 10%+ Owner $816M -$261M -24.2% Jun 27, 2025
KKR Genetic Disorder L.P. 10%+ Owner $454M -$403M -47% May 12, 2025
Neil Kumar Chief Executive Officer, Director $413M -$63.7M -13.4% Dec 4, 2025
Frank Mccormick Director $51.4M -$21.7M -29.7% Oct 29, 2025
Charles J. Homcy Director $44M -$13.9M -24% Aug 8, 2025
Thomas Trimarchi President and CFO $25.6M -$4.09M -13.8% Nov 16, 2025
Maricel Apuli Chief Accounting Officer $9.68M -$233K -2.36% Dec 8, 2025
Brian C. Stephenson CFO and Treasurer $6.44M -$2.9M -31% Feb 25, 2025
Ali J. Satvat Director $5.45M Jun 20, 2025
Andrew Lo Director $4.29M -$10.2M -70.4% Nov 17, 2025
James C. Momtazee Director $3.12M Jun 20, 2025
Richard H. Scheller Director $2.42M Feb 16, 2023
Daniels Ronald J Director $1.08M -$3.89M -78.2% Nov 6, 2025
Randal W. Scott Director $1.04M -$666K -39% Nov 17, 2025
Andrea Ellis Director $911K -$2.21M -70.8% Aug 5, 2025
Douglas A. Dachille Director $873K Jun 20, 2025
Fred Hassan Director $850K Jun 20, 2025
Hannah Valantine Director $514K -$2.48M -82.8% Nov 12, 2025
Jennifer Cook Director $451K Jun 20, 2025
Eric Aguiar Director $216K Jun 20, 2025
Brent L. Saunders Director Jun 22, 2022

Recent Insider Transactions by Companies or Individuals for BridgeBio Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.